Beryl Drugs Ltd share price logo

Beryl Drugs Share Price

BSE: 524606

Small Cap

Healthcare Sector

₹21.68

-0.32

(-1.45%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Beryl Drugs Stock Performance

as on February 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹21.00
    ₹22.25
    downward going graph

    3.14%

    Downside

    2.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹17.35
    ₹34.64
    downward going graph

    19.97%

    Downside

    59.78%

    Upside

    downward going graph

Beryl Drugs share price movements today

Previous Close
₹22.00
Open
₹22.25
Volume
15.81K
Upper Circuit
₹26.40
Lower Circuit
₹17.60
Day's Low - High
₹21.00 - ₹22.25
52 Week Low - High
₹17.35 - ₹34.64

Beryl Drugs Historical Returns

1 Month Return
-3.6 %
3 Month Return
-7.59 %
1 Year Return
-32.36 %
3 Year Return
+ 86.09 %
5 Year Return
+ 171 %

Beryl Drugs Fundamentals

as on February 10, 2026 at 4:01 pm IST

Market Cap

₹11.16 Cr

Return on Equity (ROE)

6.3

PE Ratio (TTM)

0

Return on capital employed (ROCE)

9.93

Beta (LTM)

0.48

P/B Ratio

1.13

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-440

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Beryl Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beryl Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.1634.2%0.00-121
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA3,142.8534.93%0.6969819
Curis Lifesciences Ltd image
Curis Lifesciences Ltd
NA88.93-4.4%0.00649
Denis Chem Lab Ltd image
Denis Chem Lab Ltd
NA106.9220.39%0.008173
Jagsonpal Pharmaceuticals Ltd image
Jagsonpal Pharmaceuticals Ltd
NA1,200.5594.09%0.0055268
See all

Beryl Drugs Share Price Target

Get share price movements and forecasts by analysts on Beryl Drugs.

Source: S&P Global Market Intelligence

Beryl Drugs Stock’s Investor Sentiment and Interest

Search interest for Beryl Drugs Ltd Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-3% versus previous 30 day period

Beryl Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
6.11
8.11
8.03
7.62
2.98
6.25
5.61
5.31
3.97
4.79
5.12
3.78
Total Income
6.09
8.17
8.09
7.66
3.21
6.29
5.65
5.4
5.22
4.84
5.16
3.85
Expenses
5.82
7.04
7.37
6.86
3.18
5.3
5.08
4.81
4.72
4.28
4.42
4.05
Operating Profit
0.29
1.07
0.66
0.76
-0.2
0.95
0.53
0.5
-0.75
0.51
0.7
-0.27
Operating Profit Margin %
4.75%
13.19%
8.22%
9.97%
-6.71%
15.2%
9.45%
9.42%
-18.89%
10.65%
13.67%
-7.14%
Profit Before Interest, Tax and Depreciation
0.27
1.13
0.72
0.8
0.03
0.99
0.57
0.59
0.5
0.55
0.73
-0.2
Interest
0.06
0.12
0.1
0.11
0.13
0.21
0.12
0.12
0.08
0.1
0.08
0.09
Depreciation
0.15
0.28
0.29
0.31
0.32
0.28
0.33
0.31
0.32
0.38
0.39
0.32
Profit Before Tax
0.06
0.73
0.33
0.38
-0.42
0.5
0.12
0.16
0.1
0.07
0.26
-0.61
Tax Paid
-0.01
0.2
0.06
0.06
-0.07
0.13
0.1
0.1
-0.05
0.05
0.25
-0.44
Profit After Tax
0.06
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
0.01
-0.17
Total Net profit including share of profit / Loss from associate company
0.06
0.53
0.27
0.31
-0.35
0.37
0.01
0.05
0.15
0.02
0.01
-0.17
EPS
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
Actual EPS
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
Adjusted EPS
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33
Diluted EPS
0.12
1.05
0.54
0.61
-0.68
0.73
0.01
0.1
0.3
0.04
0.02
-0.33

Beryl Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
11.27
15.25
12.96
12.82
14.09
14.6
26.89
26.73
21.15
Other Income
-
0.69
-
-
0.45
-
-
-
-
Total Income
11.53
15.94
13.2
13.05
14.73
14.77
27.16
27.12
22.55
Expenses
11.31
14.21
11.94
11.91
12.64
14.2
24.94
24.45
19.91
Operating Profit
-0.04
1.04
1.02
0.91
1.45
0.4
1.95
2.28
1.24
Operating Profit Margin %
-0.35%
6.82%
7.87%
7.1%
10.29%
2.74%
7.25%
8.53%
5.86%
Profit Before Interest, Tax and Depreciation
0.22
1.74
1.27
1.14
2.09
0.57
2.21
2.67
2.64
Interest
0.2
0.13
0.15
0.32
0.47
0.44
0.42
0.46
0.53
Depreciation
0.38
0.33
0.32
0.66
1.27
1.09
0.81
1.2
1.25
Profit Before Tax
-0.36
1.28
0.8
0.16
0.35
-0.96
0.98
1.01
0.86
Tax Paid
0.06
0.28
0.21
0.11
0.11
-0.29
0.22
0.24
0.29
Profit After Tax
-0.41
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
Total Net profit including share of profit / Loss from associate company
-0.41
0.99
0.59
0.05
0.24
-0.66
0.77
0.77
0.58
EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Actual EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Adjusted EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14
Diluted EPS
-0.82
1.96
1.16
0.09
0.47
-1.3
1.52
1.52
1.14

Beryl Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.13
0.37
-0.1
3.35
0.18
0.34
-0.29
2.48
0.82
2.64
Cash Flow from Investing Activities
0.17
0.32
0.05
1.15
-1.56
0.26
0.53
-1.3
-1.08
-0.41
Cash Flow from Financing Activities
-0.23
-0.19
-0.36
1.61
1.67
-0.54
-0.43
-1.17
0.11
-1.55
Net Cash Flow
-0.19
0.5
-0.49
-0.04
0.3
0.06
-0.18
0.01
-0.16
0.69

Beryl Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
26.38%
Public
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
73.62%
Total Outstanding Shares
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
50,71,700
Total Shareholders
6,894
6,800
6,805
6,852
7,257
7,325
7,364
7,429
7,431
7,415
7,446
7,409

Beryl Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Beryl Drugs.

  • Beryl Drugs Ltd Earnings Results

    Beryl Drugs Ltd’s net profit fell -440% since last year same period to ₹0.17Cr in the Q3 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -1800% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Beryl Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.2% return, outperforming this stock by 56.7%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 73.62% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.8% return, outperforming this stock by 82.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 26.38% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Beryl Drugs stock has moved down by -2.2%

About Beryl Drugs Ltd

Beryl Drugs Ltd is a leading generic pharmaceutical manufacturing company based in Indore, India, providing a range of branded and generic formulations, I.V.fluids, a range of small and large volume injectables, eye/ear drops, veterinary products and injections. Established in 1993, with operations taken over from M/s Flora and Fauna Remedies, Beryl Drugs have successfully set up a global network of pharmaceutical manufacturing research and development, contract manufacturing services, and veterinary products. The company is in compliance with WHO GMP specifications, and has also achieved ISO 9001:2000 certification for their quality management. Beryl Drugs are popular for many of their branded products like BERICEF injection, FNeuron Amplicillin INJ, PMol Biprox, BFlox and many more.

Revenue: ₹3.78Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.17Cr as on December 2025 (Q3 FY26)
Chairperson Name: Sudhir Sethi
OrganisationBeryl Drugs Ltd
IndustryPharmaceuticals
CEOSudhir Sethi
E-voting on sharesClick here to vote

FAQs

What is Beryl Drugs share price today?

Beryl Drugs share price today stands at ₹21.68 as on at the close of the market. Beryl Drugs share today touched a day high of ₹22.25 and a low of ₹21.

What is the 52 week high and 52 week low range for Beryl Drugs share?

Beryl Drugs touched a 52 week high of ₹34.64 and a 52 week low of ₹17.35. Beryl Drugs share price today i.e. is closed at ₹21.68, which is -37.41% down from its 52 week high and 24.96% up from its 52 week low.

What is Beryl Drugs's market capitalisation today?

Beryl Drugs market capitalisation is ₹11.16 Cr as on .

How to buy Beryl Drugs shares?

To buy Beryl Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524606 or Beryl Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beryl Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beryl Drugs trading volume today?

Beryl Drugs trading volume is 15.81K as on . This means that 15.81K shares of Beryl Drugs were bought and sold on the stock market during today's trading session.